Skip to Content

Endo International PLC ENDPQ Stock Quote

| Rating as of


Morningstar‘s Stock Analysis ENDPQ

There is no Morningstar’s Analysis data available.

Key Statistics ENDPQ

Company Profile ENDPQ

Business Description

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL. The majority of its revenue comes from the United States.

Simmonscourt Road, Ballsbridge, First Floor, Minerva House
Dublin 4, Ireland
T +353 12682000
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2022
Fiscal Year End Dec 31, 2022
Employees 3,103

Related News ENDPQ